$DAVE Cashflow Statement | Understand Stock

$DAVE

$328.47 +$5.46 (1.69%) Close

$DAVE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net income (loss)
Adjustments to reconcile net income to net cash provided by operating activities:
Interest earned on investments held in Trust Account
Depreciation and amortization
Changes in fair value of derivative asset on loans to stockholders
Provision for credit losses
Changes in fair value of earnout liabilities
Changes in fair value of public and private warrant liabilities
Transaction costs allocated to warrant liabilities
Fair value of Private Placement Warrant liability in excess of proceeds received
Stock-based compensation
Deferred income taxes
Non-cash interest
Non-cash lease expense
Changes in fair value of marketable securities and investments
Changes in operating assets and liabilities:
Prepaid expenses
ExtraCash receivables, service based revenue
Prepaid income taxes
Prepaid expenses and other current assets
Accounts payable
Accrued expenses
Legal settlement accrual
Other current liabilities
Other non-current liabilities
Other non-current assets
Interest payable, convertible notes

Net cash provided by operating activities
Investing activities
Investment of cash into Trust Account
Payments for internally developed software costs
Purchase of property and equipment
Net disbursements and collections of Member advances
Purchase of short-term investments
Sale and maturity of short-term investments
Net originations, purchases and collections of ExtraCash receivables
Purchase of investments
Sale and maturity of investments
Purchase of marketable securities
Sale of marketable securities
Net cash used in investing activities

Financing activities
Proceeds from sale of Units, net of underwriting discounts paid
Proceeds from sale of Private Placements Warrants
Repayment of promissory note - related party
Repayment on line of credit
Proceeds from PIPE offering
Proceeds from escrow account
Payment of issuance costs
Repurchases of Class A common stock
Proceeds from borrowings on convertible debt
Proceeds from borrowings on debt and credit facilities
Repayment of borrowings on credit facility
Payment for fractional shares on reverse stock split
Proceeds from issuance of common stock for stock option exercises
Payment of taxes for shares withheld related to net share settlement
Payment of costs for extinguishment of convertible debt
Repayment of borrowings on convertible debt, long-term
Net cash (used in) provided by financing activities

Net Change in Cash
Cash - Beginning of period
Cash - End of period
Offering costs paid by Sponsor in exchange for issuance of founder shares
Offering costs paid through promissory note
Deferred underwriting fee payable
Forfeiture of Founder Shares
Net increase in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash, beginning of the year
Cash and cash equivalents and restricted cash, end of the year
Supplemental disclosure of non-cash investing and financing activities:
Property and equipment purchases in accounts payable and accrued liabilities
Operating lease right of use assets recognized
Operating lease liabilities recognized
Property and equipment purchases in accounts payable
Conversion of convertible preferred stock to Class A common stock in connection with the reverse recapitalization
Recapitalization transaction costs liability incurred
Conversion of convertible notes and accrued interest to Class A common stock in connection with the reverse recapitalization
Conversion of B-1 warrants to Class A common stock in connection with the reverse recapitalization
Discharge of PIPE promissory note in connection with the reverse recapitalization
Vesting of common stock exercised early
Amendment to loan to stockholder

Supplemental disclosure of cash paid (received) for:
Income taxes
Interest
The following table provides a reconciliation of cash and cash equivalents, and restricted cash reported within the consolidated balance sheets with the same as shown in the consolidated statement of cash flows
Cash and cash equivalents
Restricted cash

Comments